<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-salinesolution91W3</udiDi>
    <basicUdiDi>B-salinesolution91W3</basicUdiDi>
    <tradeName>OPTRA-LIV</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 20ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>91</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:31:11.025Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-salinesolution34VP</udiDi>
    <basicUdiDi>B-salinesolution34VP</basicUdiDi>
    <tradeName>OPTRA-SAFE</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v - 5 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>34</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:31:04.596Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-salinesolution152J9</udiDi>
    <basicUdiDi>B-salinesolution152J9</basicUdiDi>
    <tradeName>OPTRA-SAFE</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v - 25 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>152</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:31:03.801Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-salinesolution150J5</udiDi>
    <basicUdiDi>B-salinesolution150J5</basicUdiDi>
    <tradeName>OPTRA-SAFE</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v - 2.5 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>150</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:48.805Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-salinesolution137JD</udiDi>
    <basicUdiDi>B-salinesolution137JD</basicUdiDi>
    <tradeName>OPTRA-SAFE</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v - 30 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>137</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:28.941Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-salinesolution131HZ</udiDi>
    <basicUdiDi>B-salinesolution131HZ</basicUdiDi>
    <tradeName>OPTRA-SAFE</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v - 2 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>131</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:26.554Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-saline91solutionGL</udiDi>
    <basicUdiDi>B-saline91solutionGL</basicUdiDi>
    <tradeName>EYE WASH POD</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 20 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>91</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:21.739Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-saline34solutionDB</udiDi>
    <basicUdiDi>B-saline34solutionDB</basicUdiDi>
    <tradeName>EYE WASH POD</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 5 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>34</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:20.137Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-saline152solutionL3</udiDi>
    <basicUdiDi>B-saline152solutionL3</basicUdiDi>
    <tradeName>EYE WASH POD</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 25 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>152</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:16.147Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-saline151solutionKC</udiDi>
    <basicUdiDi>B-saline151solutionKC</basicUdiDi>
    <tradeName>EYE WASH POD</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 10 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>151</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:15.516Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-saline150solutionJM</udiDi>
    <basicUdiDi>B-saline150solutionJM</basicUdiDi>
    <tradeName>EYE WASH POD</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 2.5 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>150</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:14.967Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-saline131solutionHJ</udiDi>
    <basicUdiDi>B-saline131solutionHJ</basicUdiDi>
    <tradeName>EYE WASH POD</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 2 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>131</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:02.121Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-saline124solutionJS</udiDi>
    <basicUdiDi>B-saline124solutionJS</basicUdiDi>
    <tradeName>OPTRA-LIV</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 15 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>124</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:01.319Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-saline137solutionMU</udiDi>
    <basicUdiDi>B-saline137solutionMU</basicUdiDi>
    <tradeName>EYE WASH POD</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 30 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>137</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-15T11:30:00.519Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-USMF0000389680021506A</udiDi>
    <basicUdiDi>B-USMF0000389680021506A</basicUdiDi>
    <tradeName>D-USMF0000389680021506A</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Johnson &amp; Johnson Surgical Vision, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000038968</manufacturerSrn>
    <authorisedRepresentativeName>AMO Ireland</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000013513</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VT585</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-15T10:09:28.018Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-USMF0000389680021466K</udiDi>
    <basicUdiDi>B-USMF0000389680021466K</basicUdiDi>
    <tradeName>D-USMF0000389680021466K</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Johnson &amp; Johnson Surgical Vision, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000038968</manufacturerSrn>
    <authorisedRepresentativeName>AMO Ireland</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000013513</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030203</emdnCode>
    <emdnDescription>OPHTHALMIC SURGERY BALANCED SALINE SOLUTIONS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>15020</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-15T10:09:10.310Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000044XT</udiDi>
    <basicUdiDi>B-SEMF000017467000044XT</basicUdiDi>
    <tradeName>D-SEMF000017467000044XT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10271016</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:54.941Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000043XR</udiDi>
    <basicUdiDi>B-SEMF000017467000043XR</basicUdiDi>
    <tradeName>D-SEMF000017467000043XR</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10312015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:53.340Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000042XP</udiDi>
    <basicUdiDi>B-SEMF000017467000042XP</basicUdiDi>
    <tradeName>D-SEMF000017467000042XP</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10311015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:50.943Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000041XM</udiDi>
    <basicUdiDi>B-SEMF000017467000041XM</basicUdiDi>
    <tradeName>D-SEMF000017467000041XM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10310015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:49.342Z</lastUpdated>
  </row>
</eudamedExport>